AngioDynamics
ANGO
161 hedge funds and large institutions have $1B invested in AngioDynamics in 2021 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 47 increasing their positions, 66 reducing their positions, and 10 closing their positions.
170% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 10
17% more capital invested
Capital invested by funds: $859M → $1B (+$145M)
12% more funds holding
Funds holding: 144 → 161 (+17)
0.45% more ownership
Funds ownership: 96.79% → 97.23% (+0.45%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
29% less repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 66
94% less call options, than puts
Call options by funds: $32K | Put options by funds: $575K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$6.99M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$5.96M |
| 3 |
Millennium Management
New York
|
+$5.65M |
| 4 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
+$4.28M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$4.16M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
-$18.5M |
| 2 |
BlackRock
New York
|
-$4.7M |
| 3 |
State Street
Boston,
Massachusetts
|
-$4.44M |
| 4 |
ECM
Endurant Capital Management
San Mateo,
California
|
-$3.02M |
| 5 |
State of New Jersey Common Pension Fund D
Trenton,
New Jersey
|
-$2.82M |
ANGO Hedge Fund Activity: Q2 2021 in Review
161 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in AngioDynamics (ANGO) for Q2 2021, worth a combined $1B — up 17% from $859M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new ANGO positions and 10 closed out — a net gain of 17 holders — while 47 added to existing stakes and 66 trimmed.
The largest buyer was Point72 Asset Management, adding an estimated $6.99M. The largest seller was Victory Capital Management, cutting an estimated $18.5M.
- 161 institutional investors held AngioDynamics (ANGO) as of Q2 2021, up from 144 in Q1 2021.
- Funds reported $1B of AngioDynamics stock for Q2 2021, up 17% quarter-over-quarter.
- 27 funds opened new AngioDynamics positions in Q2 2021 and 10 closed out, a net change of +17 holders.
- The largest AngioDynamics buyer in Q2 2021 was Point72 Asset Management, an estimated $6.99M added.
- The largest AngioDynamics seller in Q2 2021 was Victory Capital Management, an estimated $18.5M sold.
Based on aggregated 13F filings for Q2 2021.